Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Markian Bochan"'
Autor:
Mark Redell, Markian Bochan, Thomas L Walsh, Maha Assi, Kathleen R Sheridan, Jill Massey, Anurag Gandhi, Miguel Sierra-Hoffman, David Chansolme, Ivan Soosaipillai
Publikováno v:
Open Forum Infectious Diseases
BackgroundOritavancin (ORI) is a long-acting lipoglycopeptide indicated for the treatment of adult patients with acute bacterial skin and skin structure infections (ABSSSIs) caused or suspected to be caused by susceptible Gram-positive (GP) pathogens
Autor:
Sunit-Preet Chaudhry, Shannon Tompkins, Mary Norine Walsh, James P. Adlam, K.L. Morris, Caitlin Hoefer, M. Padanilam, Erica Seasor, Giorgio Zanotti, A. Patel, R. Garcia-Cortes, Christopher T. Salerno, A. Ravichandran, Markian Bochan
Publikováno v:
Clinical transplantationREFERENCES. 34(1)
Introduction Patients with end-stage heart failure eligible for orthotopic heart transplantation (OHT) exceed the number of available donor organs. With highly effective hepatitis C virus (HCV) antiviral therapy now available, HCV+ organs are increas
Autor:
Mary Norine Walsh, Markian Bochan, A. Patel, A. James, N. Beaudrie, A. Ravichandran, K.L. Morris, Sunit-Preet Chaudhry, R. Garcia-Cortes
Publikováno v:
The Journal of Heart and Lung Transplantation. 40:S75
Purpose In 2017, discordant hepatitis C (HCV) heart transplantation was initiated in an attempt to expand the donor pool in the era of curable treatments for HCV with direct anti-viral therapies. However, long term outcome data in these patients rema
Autor:
Mary Norine Walsh, J.P. Adlam, K.L. Morris, Christopher T. Salerno, Markian Bochan, A. Ravichandran
Publikováno v:
The Journal of Heart and Lung Transplantation. 39:S19-S20
Introduction Cardiac transplant centers are now successfully utilizing hepatitis C virus (HCV) donor hearts to increase the availability of organs now that a curative treatment is available with direct acting antivirals (DAA). We present the first de
Autor:
A. Patel, Christopher T. Salerno, J.P. Adlam, Mary Norine Walsh, Giorgio Zanotti, K.L. Morris, J. Proctor, A. Haleem, Markian Bochan, R. Garcia-Cortes, A. Ravichandran, Sunit-Preet Chaudhry
Publikováno v:
The Journal of Heart and Lung Transplantation. 39:S168
Purpose Hepatitis C (HCV) organs have been increasingly utilized in solid organ transplantation since the advent of curative direct acting anti-viral (DAA) therapy. Despite the adoption of this strategy, many unanswered questions remain regarding the
Autor:
Christopher T. Salerno, M. Padanilam, A. Ravichandran, Markian Bochan, A. Patel, R. Garcia-Cortes, Sunit-Preet Chaudhry, Shannon Tompkins, J.P. Adlam, K.L. Morris
Publikováno v:
The Journal of Heart and Lung Transplantation. 38:S265
Purpose Patients with end-stage heart failure eligible for orthotopic heart transplantation (OHT) exceeds the number of available donor organs. With the introduction of curative medications for hepatitis C (HCV), these hearts are now being utilized i
Autor:
A. Patel, A. Ravichandran, Sunit-Preet Chaudhry, K.L. Morris, Markian Bochan, Christopher T. Salerno
Publikováno v:
Journal of the American College of Cardiology. 73:2189
Influenza remains a frequent cause of hospitalization and death during the winter season. Since early in March of 2018, influenza B has been more frequently reported than influenza A. While the incidence of myocarditis from influenza is rare (from 0-
Autor:
Thomas P. Schleeter, Mary Norine Walsh, S. Moainie, Jennifer A Cowger, M. Naidu, Markian Bochan, Christopher T. Salerno
Publikováno v:
The Journal of Heart and Lung Transplantation. 35:S364